Literature DB >> 16365029

Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.

Patricia G Moorman1, John Sesay, Veronica Nwosu, Janet Grubber Kane, Allan René de Cotret, Kendra Worley, Robert Millikan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16365029     DOI： 10.1158/1055-9965.EPI-05-0291

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  10 in total

1.  A new cyclo-oxygenase-2 gene variant in the Han Chinese population is associated with an increased risk of gastric carcinoma.

Authors:  Yumin Li; Wenting He; Tao Liu; Quanbao Zhang
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Theodore M Brasky; Matthew R Bonner; Kirsten B Moysich; Heather M Ochs-Balcom; Catalin Marian; Christine B Ambrosone; Jing Nie; Meng Hua Tao; Stephen B Edge; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2010-07-30       Impact factor: 4.872

3.  Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.

Authors:  W Liu; E M Poole; C M Ulrich; R J Kulmacz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

4.  Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study.

Authors:  Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Christina M Pinkston; Stephanie D Boone; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal:  Mol Carcinog       Date:  2014-10-22       Impact factor: 4.784

5.  Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.

Authors:  Diogo N Piranda; Juliana S Festa-Vasconcellos; Laura M Amaral; Anke Bergmann; Rosane Vianna-Jorge
Journal:  BMC Cancer       Date:  2010-11-08       Impact factor: 4.430

6.  Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.

Authors:  Kristine L Witt; Patricia G Moorman; Olga Kovalchuk; Nina Holland; Gladys Block; Paul R Andreassen
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

7.  Association between cyclooxygenase-2 gene polymorphisms and risk of periodontitis: a meta-analysis involving 5653 individuals.

Authors:  Ling Jiang; Hong Weng; Ming-Yue Chen; Chao Zhang; Xian-Tao Zeng
Journal:  Mol Biol Rep       Date:  2014-04-03       Impact factor: 2.316

8.  Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Association between COX2 -765G/C polymorphism and periodontitis in Chinese population: a meta-analysis.

Authors:  Zhan-Shan Zhang
Journal:  BMC Oral Health       Date:  2018-03-07       Impact factor: 2.757

10.  Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies.

Authors:  Yueqing Cao; Aihua Tan
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.